BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 15767526)

  • 1. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
    Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
    J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC; Schaid DJ; Woods JE; Crotty TP; Myers JL; Arnold PG; Petty PM; Sellers TA; Johnson JL; McDonnell SK; Frost MH; Jenkins RB
    N Engl J Med; 1999 Jan; 340(2):77-84. PubMed ID: 9887158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; van Geel B; van Putten WL; Henzen-Logmans SC; Seynaeve C; Menke-Pluymers MB; Bartels CC; Verhoog LC; van den Ouweland AM; Niermeijer MF; Brekelmans CT; Klijn JG
    N Engl J Med; 2001 Jul; 345(3):159-64. PubMed ID: 11463009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life after bilateral prophylactic mastectomy.
    Geiger AM; Nekhlyudov L; Herrinton LJ; Rolnick SJ; Greene SM; West CN; Harris EL; Elmore JG; Altschuler A; Liu IL; Fletcher SW; Emmons KM
    Ann Surg Oncol; 2007 Feb; 14(2):686-94. PubMed ID: 17103066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic bilateral mastectomy: patterns of practice.
    Metcalfe KA; Goel V; Lickley L; Semple J; Narod SA
    Cancer; 2002 Jul; 95(2):236-42. PubMed ID: 12124821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
    Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
    J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of and satisfaction with bilateral prophylactic mastectomy.
    Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F
    Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
    J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC; Lillquist PP; Edge SB
    Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
    Sacchini V; Pinotti JA; Barros AC; Luini A; Pluchinotta A; Pinotti M; Boratto MG; Ricci MD; Ruiz CA; Nisida AC; Veronesi P; Petit J; Arnone P; Bassi F; Disa JJ; Garcia-Etienne CA; Borgen PI
    J Am Coll Surg; 2006 Nov; 203(5):704-14. PubMed ID: 17084333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral prophylactic mastectomy in women with an increased risk of breast cancer.
    Tecnologica MAP Suppl; 1999 Jun; ():3-6. PubMed ID: 10848037
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral prophylactic mastectomy decision making: A vignette study.
    Stefanek M; Enger C; Benkendorf J; Flamm Honig S; Lerman C
    Prev Med; 1999 Sep; 29(3):216-21. PubMed ID: 10479610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women.
    Fryzek JP; Ye W; Nyrén O; Tarone RE; Lipworth L; McLaughlin JK
    Breast Cancer Res Treat; 2006 May; 97(2):131-4. PubMed ID: 16328720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
    Degnim AC; Visscher DW; Berman HK; Frost MH; Sellers TA; Vierkant RA; Maloney SD; Pankratz VS; de Groen PC; Lingle WL; Ghosh K; Penheiter L; Tlsty T; Melton LJ; Reynolds CA; Hartmann LC
    J Clin Oncol; 2007 Jul; 25(19):2671-7. PubMed ID: 17563394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K; Hunt KK; Gershenwald JE; Singletary SE; Mirza N; Kuerer HM; Babiera GV; Ames FC; Ross MI; Feig BW; Sahin AA; Arun B; Meric-Bernstam F
    Cancer; 2004 Nov; 101(9):1977-86. PubMed ID: 15389473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.